Wednesday, August 16, 2023 | The Latest Research, Commentary, And News From Health Affairs
Dear John,
ICYMI: Alan Weil interviewed Meena Seshamani for a crossover podcast event with A Health Podyssey and our Policy
Spotlight event series.
ROI of Malaria Vaccine in Sub-Saharan Africa Malaria remains a significant global health concern, with over 200 million estimated malaria cases reported worldwide in 2021, and 95 percent of these cases occurring in the World Health Organization (WHO) African Region.
In the August issue of Health Affairs, Joshua Mak and his colleagues at Johns Hopkins University calculate the return on investment (ROI) for the introduction and continuation of a four-dose malaria vaccine from 2021–30 in twenty sub-Saharan African countries.
After using the Swiss Tropical and Public Health Institute's model, they estimate a base ROI of 0.42, estimating that the malaria vaccine would avert $4.04 billion in cost of illness between 2021–30. After using the Imperial College London Model, they estimate a base ROI of 2.3 and $9.41 billion in cost of illness averted.
Both calculations indicate that the introduction and implementation of the malaria vaccine has resulted in a positive ROI.
Health Affairs is the leading peer-reviewedjournalat the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking
content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
